Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AVRO

AVROBIO (AVRO) Stock Price, News & Analysis

AVROBIO logo

About AVROBIO Stock (NASDAQ:AVRO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.40
$18.24
52-Week Range
N/A
Volume
206,800 shs
Average Volume
269,831 shs
Market Capitalization
$62.85 million
P/E Ratio
2.03
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AVRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter.

AVRO Stock News Headlines

I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
L'action TECX atteint un sommet sur 52 semaines à 53,41$
See More Headlines

AVRO Stock Analysis - Frequently Asked Questions

AVROBIO, Inc. (NASDAQ:AVRO) announced its earnings results on Thursday, November, 4th. The company reported ($9.00) EPS for the quarter, hitting the consensus estimate of ($9.00).

AVROBIO's stock reverse split before market open on Thursday, June 20th 2024.The 1-12 reverse split was announced on Thursday, June 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

AVROBIO (AVRO) raised $75 million in an IPO on Thursday, June 21st 2018. The company issued 4,400,000 shares at $16.00-$18.00 per share. Morgan Stanley, Cowen and Wells Fargo Securities acted as the underwriters for the IPO and Wedbush Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that AVROBIO investors own include Meta Platforms (META), NVIDIA (NVDA), CymaBay Therapeutics (CBAY), Broadcom (AVGO), CrowdStrike (CRWD), Advanced Micro Devices (AMD) and Adobe (ADBE).

Company Calendar

Last Earnings
11/04/2021
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:AVRO
CIK
1681087
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.69
Trailing P/E Ratio
2.03
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$12.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-50.52%
Return on Assets
-47.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
26.17
Quick Ratio
26.17

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.13 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
44,890,000
Free Float
40,764,000
Market Cap
$62.85 million
Optionable
Optionable
Beta
1.23
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:AVRO) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners